Context Therapeutics Inc. (CNTX) Misses Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts CNTX Hot Sheet
Join SI Premium – FREE
Context Therapeutics Inc. (NASDAQ: CNTX) reported Q2 EPS of ($0.15), $0.06 worse than the analyst estimate of ($0.09).
For earnings history and earnings-related data on Context Therapeutics Inc. (CNTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nucor projects Q3 2026 earnings above prior year, below estimates
- Barclays Reinstates Smiths Group (SMIN:LN) (SMGKF) at Equalweight
- Barclays Starts Hill & Smith Holdings Plc. (HILS:LN) at Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
